Chromogranin A Expression in Patients With Hormone Naïve Prostate Cancer Predicts the Development of Hormone Refractory DiseaseAlfredo Berruti, Luigi Dogliotti, Lucianna Russo et al.|The Journal of Urology|2007Cited by 89
Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer: a validation study on an Italian patient population undergoing first and repeat biopsy.Enrico Bollito, Donato Randone, Stefano De Luca et al.|PubMed|2012Cited by 21
Fluctuation in prostate cancer gene 3 ( <scp>PCA3</scp> ) score in men undergoing first or repeat prostate biopsiesStefano De Luca, F. Porpiglia, Roberto Passera et al.|British Journal of Urology|2014Cited by 10
Biopsy and radical prostatectomy pathological patterns influence Prostate cancer gene 3 (PCA3) score.Stefano De Luca, Donato Randone, Roberto Passera et al.|PubMed|2013Cited by 7